CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on Prostate Cancer News http://www.cancercompass.com/prostate-cancer-news.htm Sat, 21 Nov 2009 00:00:00 GMT Sat, 21 Nov 2009 00:00:00 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Synta Pharmaceuticals Corp, a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models. http://www.cancercompass.com/cancer-news/article/32436.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths. http://www.cancercompass.com/cancer-news/article/32421.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information. http://www.cancercompass.com/cancer-news/article/32422.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT A long-term study has found that men with low- grade, slow-growing prostate cancer who are managed with active surveillance and no radical treatment have an extremely high survival rate. http://www.cancercompass.com/cancer-news/article/32442.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT According to a study from the United States, Previously, we reported that caveolin-1 (cav-1) is overexpressed in metastatic prostate cancer and that virulent prostate cancer cells secrete biologically active cav-1. http://www.cancercompass.com/cancer-news/article/32396.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the Journal of the American Medical Association. http://www.cancercompass.com/cancer-news/article/32403.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT Several components of the Writ signaling cascade have been shown to function either as tumor suppressor proteins or as oncogenes in multiple human cancers, underscoring the relevance of this pathway in oncogenesis and the need for further investigation of Wnt signaling components as potential targets for cancer therapy. http://www.cancercompass.com/cancer-news/article/32411.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT Fresh data on prostate cancer are presented in the report Robot-assisted radical prostatectomy in men aged > or p years. http://www.cancercompass.com/cancer-news/article/32412.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT Men who receive a boost of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago. http://www.cancercompass.com/cancer-news/article/32413.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT A patient's socioeconomic status (income, martial status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. http://www.cancercompass.com/cancer-news/article/32414.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT According to recent research published in the journal Clinical Cancer Research, The transmembrane molecule, translocator protein (TSPO), has been implicated in the progression of epithelial tumors. http://www.cancercompass.com/cancer-news/article/32415.htm CancerCompass Sat, 14 Nov 2009 00:00:00 GMT According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS). http://www.cancercompass.com/cancer-news/article/32433.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the only agent currently approved by the FDA to treat patients with relapsed or refractory peripheral T-cell lymphoma. Investigators from NCCN Member Institutions are eligible to apply for the research funding. http://www.cancercompass.com/cancer-news/article/32382.htm CancerCompass Tue, 10 Nov 2009 00:00:00 GMT New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. http://www.cancercompass.com/cancer-news/article/32384.htm CancerCompass Tue, 10 Nov 2009 00:00:00 GMT A new U.S. study has shown that green tea may help reduce the risk of oral cancer, although scientists are reluctant to officially endorse green tea as an effective way of cancer prevention. http://www.cancercompass.com/cancer-news/article/32387.htm CancerCompass Tue, 10 Nov 2009 00:00:00 GMT Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. http://www.cancercompass.com/cancer-news/article/32363.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT Drugs used to treat psychiatric disorders are highly effective at killing cancer cells, opening up potential new lines of treatments. Dr Louise Lurze-Mann of the University of NSW School of Biotechnology and Biomolecular Sciences was talking with psychiatric researchers at the University of Queensland when they mentioned that people with diseases like schizophrenia appear to have low rates of cancer, despite being more inclined to smoke than the general population. http://www.cancercompass.com/cancer-news/article/32367.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting. http://www.cancercompass.com/cancer-news/article/32364.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do. http://www.cancercompass.com/cancer-news/article/32365.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT U.S. scientists say they have discovered a small molecule that inhibits the actions of a protein cancer cells require for survival. The researchers said they determined the molecule, called PES, inhibits a type of protein called a heat-shock protein that helps cells survive heat, lack of nutrients and other cell-damaging conditions. http://www.cancercompass.com/cancer-news/article/32368.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT